• 名称: HCC1806(人乳腺癌细胞)
  • 货号: CBP60373
  • 浏览次数: 589
  • 已销售数量:0件
  • 评论信息
  • 购买数量:  购买数量不能低于最少订购数量!

购买 询价 收藏 QQ交流 好友推荐

CBP60373
I. General information 
Synonyms: HCC1806
Background: The HCC1806 breast cancer cell line was initiated on July 31, 1995, and took 10 months to establish.
Species: Homo sapiens, human
Tissue: mammary gland; breast
Disease: TNM stage IIB, grade 2, primary acantholytic squamous cell carcinoma
Gender: female, 60 years, Black
Morphology: epithelial
Growth Mode: adherent, The line grows as attached medium-sized epithelial cells without floating cells.
DNA Profile: D5S818: 13
D13S317: 11
D7S820: 10, 12
D16S539: 10
vWA: 16, 18
TH01: 8
Amelogenin: X
TPOX: 8, 9
CSF1PO: 12
Cobioer’s Cell Line Authentication Service
Culture Medium: RPMI-1640+10%FBS
We strongly suggest to purchase the complete medium from Cobioer.
Cryopreservation medium: 90%FBS+10%DMSO
Receptor Expression: estrogen receptor, negative
progesterone receptor, negative
Oncogene: her2/neu -, p53 -
Genes Expressed: Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
Cellular Products: Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
Comments: The tumor was classified as a TNM Stage IIB, grade 2, acantholytic squamous carcinoma with no lymph node metastasis.
There was no family history of breast cancer.
The cells are poorly differentiated.
The cells are negative for expression of Her2-neu and for expression of p53.
HCC1806 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2) and for cytokeratin 19.
The cells are negative for expression of estrogen receptor (ER) and for expression of progesterone receptor (PR).
The cells are homozygous for deletions in the FHIT gene at 3p14.2.
For more information, please contact Cobioer (4008-750-250).

关键词: